Boundless Bio’s $100 Million IPO

Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Boundless Bio on the offering, and Cooley advised the underwriters.Boundless Bio, Inc. (Nasdaq: BOLD) a clinical stage…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now